Research ArticleArticle
Serum Uric Acid and the Risk of Incident and Recurrent Gout: A Systematic Review
Aki Shiozawa, Shelagh M. Szabo, Anna Bolzani, Antoinette Cheung and Hyon K. Choi
The Journal of Rheumatology February 2017, jrheum.160452; DOI: https://doi.org/10.3899/jrheum.160452
Aki Shiozawa
From Takeda Pharmaceuticals International Inc., Deerfield, Illinois; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Redwood Outcomes, Vancouver, British Columbia, Canada. Funded by Takeda Pharmaceuticals International Inc. A. Shiozawa, Associate Director, MPH, Takeda Pharmaceuticals International Inc.; S.M. Szabo, Principal, MSc, Redwood Outcomes; A. Bolzani, Research Associate, MSc, Redwood Outcomes; A. Cheung, Research Associate, MPH, Redwood Outcomes; H.K. Choi, Professor, Director, MD, DrPH, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School. Address correspondence to Ms. S.M. Szabo, Broadstreet HEOR, 301 - 343 Railway St., Vancouver, British Columbia V6A 1A4, Canada. E-mail: sszabo@broadstreetheor.com. Accepted for publication November 23, 2016.
Shelagh M. Szabo
From Takeda Pharmaceuticals International Inc., Deerfield, Illinois; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Redwood Outcomes, Vancouver, British Columbia, Canada. Funded by Takeda Pharmaceuticals International Inc. A. Shiozawa, Associate Director, MPH, Takeda Pharmaceuticals International Inc.; S.M. Szabo, Principal, MSc, Redwood Outcomes; A. Bolzani, Research Associate, MSc, Redwood Outcomes; A. Cheung, Research Associate, MPH, Redwood Outcomes; H.K. Choi, Professor, Director, MD, DrPH, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School. Address correspondence to Ms. S.M. Szabo, Broadstreet HEOR, 301 - 343 Railway St., Vancouver, British Columbia V6A 1A4, Canada. E-mail: sszabo@broadstreetheor.com. Accepted for publication November 23, 2016.
Anna Bolzani
From Takeda Pharmaceuticals International Inc., Deerfield, Illinois; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Redwood Outcomes, Vancouver, British Columbia, Canada. Funded by Takeda Pharmaceuticals International Inc. A. Shiozawa, Associate Director, MPH, Takeda Pharmaceuticals International Inc.; S.M. Szabo, Principal, MSc, Redwood Outcomes; A. Bolzani, Research Associate, MSc, Redwood Outcomes; A. Cheung, Research Associate, MPH, Redwood Outcomes; H.K. Choi, Professor, Director, MD, DrPH, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School. Address correspondence to Ms. S.M. Szabo, Broadstreet HEOR, 301 - 343 Railway St., Vancouver, British Columbia V6A 1A4, Canada. E-mail: sszabo@broadstreetheor.com. Accepted for publication November 23, 2016.
Antoinette Cheung
From Takeda Pharmaceuticals International Inc., Deerfield, Illinois; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Redwood Outcomes, Vancouver, British Columbia, Canada. Funded by Takeda Pharmaceuticals International Inc. A. Shiozawa, Associate Director, MPH, Takeda Pharmaceuticals International Inc.; S.M. Szabo, Principal, MSc, Redwood Outcomes; A. Bolzani, Research Associate, MSc, Redwood Outcomes; A. Cheung, Research Associate, MPH, Redwood Outcomes; H.K. Choi, Professor, Director, MD, DrPH, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School. Address correspondence to Ms. S.M. Szabo, Broadstreet HEOR, 301 - 343 Railway St., Vancouver, British Columbia V6A 1A4, Canada. E-mail: sszabo@broadstreetheor.com. Accepted for publication November 23, 2016.
Hyon K. Choi
From Takeda Pharmaceuticals International Inc., Deerfield, Illinois; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Redwood Outcomes, Vancouver, British Columbia, Canada. Funded by Takeda Pharmaceuticals International Inc. A. Shiozawa, Associate Director, MPH, Takeda Pharmaceuticals International Inc.; S.M. Szabo, Principal, MSc, Redwood Outcomes; A. Bolzani, Research Associate, MSc, Redwood Outcomes; A. Cheung, Research Associate, MPH, Redwood Outcomes; H.K. Choi, Professor, Director, MD, DrPH, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School. Address correspondence to Ms. S.M. Szabo, Broadstreet HEOR, 301 - 343 Railway St., Vancouver, British Columbia V6A 1A4, Canada. E-mail: sszabo@broadstreetheor.com. Accepted for publication November 23, 2016.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Serum Uric Acid and the Risk of Incident and Recurrent Gout: A Systematic Review
Aki Shiozawa, Shelagh M. Szabo, Anna Bolzani, Antoinette Cheung, Hyon K. Choi
The Journal of Rheumatology Feb 2017, jrheum.160452; DOI: 10.3899/jrheum.160452